Over the coming weeks, millions of Covid-19 vaccine doses will be distributed to over 100 countries simultaneously. Logistically, the challenge is two-fold. As Covid-19 vaccines have serious temperature constraints that need to be rigorously monitored continuously throughout the logistics process, distribution needs to both manage multiple transportation and storage stages in thousands of different points across each country, as well as maintaining the environmental parameters within the regulation-compliant ranges, which in some cases exceed -70 ºC, depending on the vaccine.
Combining Eupry’s wireless data loggers with Atos’ long-standing expertise in automation and monitoring together with its ability to successfully implement large projects on a global scale, the joint solution safeguards the logistics process end-to-end via a single platform. Eupry’s loggers monitor temperatures from -200°C to 800°C, as well as differential pressure, humidity and carbon dioxide across the logistics chain (fridge, freezer, transport and storage).
The joint solution offers a fully automated service which optimizes resources and eliminates the risk of error and breach of compliance, including:
Monitoring, alerting and maintaining transportation & shipment compliance, tailored to customers’ needs
The solution is IT-validated
Compliant towards FDA PART11
Data loggers are shipped with ISO17025 calibrated (accredited) certificates
Built-in, end-to-end traceability with location tracking
Scalability from one up to thousands of units
Robust and proven security solutions backed by Atos’ expertise
Niels Thomsen, Group Vice President, Global Head of the Insight (IoT & AI) practice at Atos said: “The toll of Covid-19 on all aspects of our lives has been devastating and the vaccines offers us hope for a better 2021. Organizing their distribution all over the world in such a short time will be an extremely complex operation and we are proud to contribute, at our level, by partnering with Eupry to offer a solution that can simplify the work of those directly involved.”
Christian Herschend Jacobsen, CEO at Eupry said: “It is amazing how fast the life science industry today can develop hope for a brighter future. From our experience with UNICEF we know it is a major task to manufacture and distribute vaccines to billions of people world-wide and this is still ahead of us. It’s essential that we do not waste or damage vaccines due to wrong storage conditions. We need to utilize technology to free already overburdened health personal from manual processes including quality assurance. We – Eupry - started our journey back in 2012 helping Unicef and Clinton Health Access Initiative in their pursuit to deliver better quality in vaccine distribution, and we managed to make a compliance service exactly for this kind of situation.”